Document Detail


New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease.
MedLine Citation:
PMID:  23162554     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
KIR3DL2/CD158k/p140 is a three domain killer cell immunoglobulin-like receptor incorporating cytoplasmic immunoreceptor tyrosine inhibitory motifs, expressed as a disulphide-bonded dimer. KIR3DL2 is a framework gene within the KIR locus and is highly polymorphic, with 62 allelic variants possibly coding for protein reported. KIR3DL2 binds to HLA-A3 and -A11 in a peptide-dependent fashion and to B27 free heavy chain forms. In addition, KIR3DL2 can also function as an innate immune receptor for delivery of CpG DNA to TLR9 in NK cells. The increased levels of expression of KIR3DL2 compared with other KIR expressed by T cell subsets in healthy individuals suggest it may function as a default KIR receptor. KIR3DL2-expressing natural killer (NK) cells and IL17 secreting CD4 T cells have been implicated in the pathogenesis of ankylosing spondylitis. Moreover, KIR3DL2 expression delineates circulating and cutaneous lymphoma T cells in Sézary's syndrome. Here we discuss how the unique molecular attributes of KIR3DL2 impact on its function on NK and T cells and how this may relate to its role in disease.
Authors:
Jacqueline Shaw; Simon Kollnberger
Related Documents :
24659564 - Characterization and in-vitro differentiation potency of early-passage canine amnion- a...
24094324 - Sox2(+) stem/progenitor cells in the adult mouse pituitary support organ homeostasis an...
12720294 - Overexpression of the immunoglobulin superfamily members cdo and boc enhances different...
23333864 - Impaired selection of iga and intestinal dysbiosis associated with pd-1-deficiency.
18691294 - Induction of t-helper type 2 cytokine release and up-regulated expression of protease-a...
21837654 - Action at a distance: systemically administered adult stem/progenitor cells (mscs) redu...
Publication Detail:
Type:  Journal Article     Date:  2012-11-16
Journal Detail:
Title:  Frontiers in immunology     Volume:  3     ISSN:  1664-3224     ISO Abbreviation:  Front Immunol     Publication Date:  2012  
Date Detail:
Created Date:  2012-11-19     Completed Date:  2012-11-20     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  101560960     Medline TA:  Front Immunol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  339     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
19380//Arthritis Research UK; 19807//Arthritis Research UK
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human NK cell lytic granules and regulation of their exocytosis.
Next Document:  Local immunity by tissue-resident CD8(+) memory T cells.